Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial

Rasmus Sejersten Ripa; Yongzhong Wang; Erik Jørgensen; Hans Erik Johnsen; Peer Grande; Jens Kastrup

Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial

Rasmus Sejersten Ripa, Yongzhong Wang, Erik Jørgensen, Hans Erik Johnsen, Peer Grande, Jens Kastrup

Original language	English
Journal	HeartDrug
Volume	5
Pages (from-to)	177-82
Number of pages	6
Publication status	Published - 2005
Externally published	Yes

Cite this

Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial. / Ripa, Rasmus Sejersten; Wang, Yongzhong; Jørgensen, Erik et al.

In: HeartDrug, Vol. 5, 2005, p. 177-82.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{4ea276f4504341dba062addef9dd1c63,

title = "Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial",

author = "Ripa, {Rasmus Sejersten} and Yongzhong Wang and Erik J{\o}rgensen and Johnsen, {Hans Erik} and Peer Grande and Jens Kastrup",

year = "2005",

language = "English",

volume = "5",

pages = "177--82",

journal = "HeartDrug",

}

TY - JOUR

T1 - Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial

AU - Ripa, Rasmus Sejersten

AU - Wang, Yongzhong

AU - Jørgensen, Erik

AU - Johnsen, Hans Erik

AU - Grande, Peer

AU - Kastrup, Jens

PY - 2005

Y1 - 2005

M3 - Journal article

VL - 5

SP - 177

EP - 182

JO - HeartDrug

JF - HeartDrug

ER -